AKT1 and acute lymphoblastic leukemia: These results strongly imply that PTEN/PI3K/AKT/mTOR signaling pathways mediates the effects of MTE on Jurkat cells, and provide a novel tool for treatment T-ALL, enhancement PTEN levels.